Anthracosis of lung: evaluation of potential underlying causes Source: Eur Respir J 2005; 26: Suppl. 49, 304s Year: 2005
The inhibitory effect of fenretinide on the expression of inflammatory cytokines, possible molecular target of the drug and its relevance to cystic fibrosis. Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009
Clinical relevance of COPD muscle dysfunction and body composition alterations, and their risk factors and underlying mechanisms Source: International Congress 2016 – PG15 Muscle weakness and wasting in chronic obstructive pulmonary disease Year: 2016
Molecular variations underlying the heterogeneity in lung function in COPD Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes Year: 2017
Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019 Year: 2020
COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects Source: Eur Respir Rev, 30 (161) 210055; 10.1183/16000617.0055-2021 Year: 2021
The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006
Some pathogenetic mechanisms of inflammatory processes in smoking patients with COPD Source: Annual Congress 2007 - Smoking and the lung Year: 2007
Latent TGF-ß binding protein 4 is an important factor that influences anti-inflammatory and cell-protective responses in the pathogenesis of pulmonary emphysema Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease Year: 2020
To the molecular genetic mechanisms of the COPD pathogenesis Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018
Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015
The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury Source: ERS Lung Science Conference 2017 Year: 2017
The impact of different asthma phenotypes on the outcome Source: Annual Congress 2012 - Asthma from childhood to adulthood: what factors predict the outcome? Year: 2012
Mechanisms underlying nicotine dependency Source: International Congress 2014 – End of the tobacco epidemic: from individual to societal strategies Year: 2014
Is the association between physical activity and lung function due to reverse causation? An application of exploratory and causal approaches Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
Possible role of airway mechanical stress in the genesis of COPD in smokers. The obesity model Source: Eur Respir J 2005; 26: Suppl. 49, 360s Year: 2005
Interstitial lung disease induced by exogenous agents: factors governing susceptibility Source: Eur Respir J 2001; 18: 30S-42S Year: 2001
The impact of a network based approach on lung function and symptom duration at diagnosis in idiopathic pulmonary fibrosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018